Graph Therapeutics
Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis
$5MSeries A
Role not disclosedD
Daphni
Activity from announced rounds
Activity in this selectionJun 30, 2026 · AI · Jun 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $18M 2 disclosed · full round size, not this investor’s share